BMS-737
Product Specifications
CAS Number
1356053-63-8
Target
Cytochromes P450
Related Pathways
Metabolism
Bioactivity
BMS-737 (compound 33), a non-steroidal, reversible small molecule inhibitor, demonstrates 11-fold selectivity for CYP17 lyase over CYP17 hydroxylase. This compound is engineered to target castration-resistant prostate cancer (CRPC) and effectively lowers testosterone levels, while maintaining stable orrodermal hormone and glucocorticoid levels.
Smiles
FC1=CC=C(C=C1)N2N=CC=3C2=NC=CC3C=4C=NC=NC4N
Molecular Formula
C16H11FN6
Molecular Weight
306.3
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
144479 100 µg
EIF6 (EIF3A, ITGB4BP, b (2) gcn, B (2) GCN homolog, B4 integrin interactor, CAB, p27 (BBP), integrin beta 4 binding protein, p27, BETA-4 N, Eukaryotic translation initiation factor 6, 3A)
Sign In for Pricing
View Details 
PCRS96-0.2BC 10pcs/box. 5boxes/ctn
96x0.2, semi skirted, transparent frame + transparent tube, A12, detachable
Sign In for Pricing
View Details GTR15333021 1 Vial
Lentiviral human PAQR9 shRNA (UAS) - Lentiviral human PAQR9 shRNA (UAS) (100)
Sign In for Pricing
View Details 322154 100 µL
LAMP2 (Lysosome-Associated Membrane Glycoprotein 2, LAMP-2, Lysosome-Associated Membrane Protein 2, CD107 Antigen-like Family Member B, CD107b) discontinued
Sign In for Pricing
View Details